| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/01/1989 | EP0301742A2 Paraherquamide and dihydroparaherquamide as antiparasitic agents |
| 02/01/1989 | EP0301670A1 Kluyveromyces as a host strain |
| 02/01/1989 | EP0301669A1 DNA constructs containing a Kluyveromyces alpha-factor leader sequence for directing secretion of heterologous derivatives |
| 02/01/1989 | EP0301628A1 Fructosyl transferase and the preparation of fructose oligomers therewith |
| 02/01/1989 | EP0301572A2 Process for producing l-threonine by fermentation |
| 02/01/1989 | EP0301485A1 Expression vectors and processes using same in the production of cro/beta-galactosidase/PTH fusion proteins and of PTH |
| 02/01/1989 | EP0301247A2 De-mannosyl teicoplanin derivatives |
| 02/01/1989 | EP0301235A2 Method for producing novel dried compositions containing polysaccharides |
| 02/01/1989 | EP0301107A1 Process for preparing d-alanine |
| 02/01/1989 | EP0138948B1 Dna sequence encoding an exo-signal |
| 02/01/1989 | CN1030787A Molecular cloning and expression of genes encoding proteolytic enzymes |
| 02/01/1989 | CN1030766A Enkastine-glycopeptide of action having inhibitory encephalinase, process for preparing them and pharamaceutical use |
| 01/31/1989 | US4801686 Suspension, microbial cells, breaking, extraction |
| 01/31/1989 | US4801542 Expression of biologically active PDGF analogs in eucaryotic cells |
| 01/31/1989 | US4801539 Fermentation method for producing hyaluronic acid |
| 01/26/1989 | WO1989000692A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/26/1989 | WO1989000603A1 A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein |
| 01/26/1989 | WO1989000599A1 Production of hblv virus in the hsb-2 cell line |
| 01/26/1989 | WO1989000582A2 Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 01/26/1989 | WO1989000581A1 Lectines fixing beta-d-galactoside |
| 01/26/1989 | WO1989000547A1 Process for nitrification and nitrogen removal by nitrifying bacteria |
| 01/26/1989 | WO1988007576A3 Vascular anticoagulant proteins, dnas which code for them, manufacture and application thereof |
| 01/25/1989 | EP0300988A2 Tissue factor inhibitor |
| 01/25/1989 | EP0300973A1 Physiologically active substances, a process for the preparation thereof and pharmaceutical compositions containing them |
| 01/25/1989 | EP0300867A2 Process and apparatus for the culture of microorganisms, and use, particularly in the production of ligninase |
| 01/25/1989 | EP0300674A2 Directed biosynthesis of milbemycin analog |
| 01/25/1989 | EP0300425A2 Method for the production of proteins in a soluble form |
| 01/25/1989 | EP0300422A2 An improved method for preparing stable and viable recombinant animal cell viral vectors |
| 01/25/1989 | EP0300409A1 Process for the production of human tissue plasminogen activator and cell strain useful therefor |
| 01/25/1989 | EP0300294A2 Novel compound DC-107 and process for its preparation |
| 01/25/1989 | EP0300273A2 AB-006 antibiotics and process for their production |
| 01/25/1989 | EP0300213A1 Hepatitis a viral peptide particle immunogens |
| 01/25/1989 | EP0300030A1 Human proteins having anticoagulant and anti-inflammatory activity |
| 01/25/1989 | EP0137786B1 Hyaluronic acid from bacterial culture |
| 01/25/1989 | CN1030645A Immunodiagnostic assays using chimeric antigens |
| 01/25/1989 | CN1030611A Monoclonal antibody specific for adhesion function domain of phagocyte cell surface protein |
| 01/25/1989 | CN1030610A Monoclonal antibody specific to common determinant site of neutrophils and eosinophils |
| 01/25/1989 | CN1030609A Protein with 8th activity factor,process for its preparation using genetic engineering cell and pharmaceutical composition containing it |
| 01/24/1989 | US4800161 Cultivation of acinetobacter |
| 01/24/1989 | CA1249235A1 4'-deschlororebeccamycin and process for its preparation |
| 01/24/1989 | CA1249234A1 Xenocoumacins |
| 01/18/1989 | EP0299828A1 Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications |
| 01/18/1989 | EP0299810A1 Process for the production of polypeptides by recombinant DNA |
| 01/18/1989 | EP0299790A2 Recombinant C-terminal alpha-amidating enzyme |
| 01/18/1989 | EP0299782A2 Expression vectors for the production of human Granulocyte-Macrophage Colony Stimulation Factor in a mammalian cell host(18.05.92) |
| 01/18/1989 | EP0299707A2 Glycopeptide antibiotics |
| 01/18/1989 | EP0299706A2 Nonglycosylated plasminogen activator and method of preparation |
| 01/18/1989 | EP0299559A1 Process for the preparation of 2-aryloxypropionic acids |
| 01/18/1989 | EP0299558A1 Process for the preparation of ibuprofen |
| 01/18/1989 | EP0299354A2 Monoclonal antibodies against protein E7 of the human papilloma virus type 16, their production process and their use |
| 01/18/1989 | EP0299242A2 Heterologous viral peptide particle immunogens |
| 01/18/1989 | EP0299206A2 Recombinant human ADF |
| 01/18/1989 | EP0299127A1 A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein |
| 01/18/1989 | EP0299108A1 DNA-molecules coding for FMDH control regions and structured gene for a protein having FMDH-activity and their uses |
| 01/18/1989 | EP0299028A1 Process for producing l-aminoacids. |
| 01/18/1989 | EP0299009A1 Method for preparing alcoholic drinks from vegetable juice. |
| 01/18/1989 | EP0143809B1 Method for obtaining human hepatocytes cultures, cultures obtained thereby and biological and biochemical applications thereof |
| 01/17/1989 | US4798807 Monoclonal antibodies and method for detecting dioxins and dibenzofurans |
| 01/17/1989 | US4798797 Retrovirus associated with lymphadenopathies and adapted to continuous lines of lymphoblastoid B cells, capable of producing retrovirus continuously and process for their production |
| 01/17/1989 | US4798796 Cell lines and their use for the production plasminogen activators |
| 01/17/1989 | US4798791 Vector for high level gene expression |
| 01/17/1989 | US4798790 Monoclonal antibody specific for a pigmentation associated antigen |
| 01/17/1989 | CA1248898A1 Production of l-amino acids by transamination |
| 01/17/1989 | CA1248897A1 Tetracyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 01/17/1989 | CA1248894A1 Synthetic peptide-based anti-rabies compositions and methods |
| 01/12/1989 | WO1989000203A1 A method for the preparation of "natural" methyl anthranilate |
| 01/12/1989 | WO1989000200A1 Peptides and antibodies that inhibit platelet adhesion |
| 01/12/1989 | WO1989000198A1 Recombinant fibroblast growth factors |
| 01/12/1989 | WO1989000196A1 Virus proteins having reduced o-linked glycosylation |
| 01/12/1989 | WO1989000190A1 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein |
| 01/12/1989 | WO1989000169A1 Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils |
| 01/12/1989 | WO1989000163A1 Vaccines against animal parasitic nematodes |
| 01/12/1989 | WO1989000050A1 Antigen recognized by mca 16-88 |
| 01/12/1989 | WO1989000048A1 Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications |
| 01/12/1989 | WO1988009818A3 Growth hormone receptor |
| 01/11/1989 | EP0298807A1 Method for the production of stable cell lines from transgenic animals for the production of specific proteins; tumour cell lines and proteins obtained |
| 01/11/1989 | EP0298723A1 Recombinant fibroblast growth factors |
| 01/11/1989 | EP0298645A2 Polypeptide possessing maltotetraose-forming amylase activity, and its uses |
| 01/11/1989 | EP0298640A1 A new antimicrobial agent, fr 109615 and production thereof |
| 01/11/1989 | EP0298605A1 Process for producing a stable bacterial composition and process for breadmaking using this composition |
| 01/11/1989 | EP0298436A2 Use of a vehicle with a high tumour affinity |
| 01/11/1989 | EP0298088A1 Production and diagnostic use of antibodies against pancreatic alpha-amylase |
| 01/10/1989 | US4797929 Word recognition in a speech recognition system using data reduced word templates |
| 01/10/1989 | US4797473 Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins |
| 01/10/1989 | US4797370 Antigens, bonding, immunology |
| 01/10/1989 | US4797360 Conversion of sucrose to fructose and ethanol |
| 01/10/1989 | US4797356 Monoclonal antibodies specific to glactosyltransferase isoenzyme II and their use in cancer immunoassays |
| 01/10/1989 | US4797279 Insecticidal hybrid bacteria from b.t. kurstaki and b.t. tenebrionis |
| 01/10/1989 | US4796805 Ice making method using ice nucleating microorganisms |
| 01/10/1989 | CA1248473A1 Selectable markers for yeast transformation |
| 01/10/1989 | CA1248472A1 Monoclonal antibodies specific to in vivo fragments derived from fibrinogen |
| 01/10/1989 | CA1248448A1 PURIFICATION OF BIOLOGICALLY ACTIVE HUMAN IMMUNE INTERFERON-.gamma. |
| 01/04/1989 | EP0297946A2 Cytochalasin purification methods and compositions |
| 01/04/1989 | EP0297930A2 Monoclonal antibodies |
| 01/04/1989 | EP0297882A2 Hybrid plasminogen activators |
| 01/04/1989 | EP0297833A2 Physiologically active lymphotoxin |
| 01/04/1989 | EP0297807A1 Novel prokaryotic expression and secretion system |
| 01/04/1989 | EP0297619A2 Process for the preparation of L-phenyl alanine from benzylidene hydantoin |
| 01/04/1989 | EP0297618A2 Phosphinothricin-resistant gene and its use |
| 01/04/1989 | EP0297585A2 Neuronal polypeptide and methods of production and use thereof |